Posted by Michael Wonder on 08 Apr 2019
Plan to end drug rebates adds protections for insurers
5 April 2019 - Administration’s move to backstop losses could prevent premiums from rising significantly.
The Trump administration said the federal government would offer a risk-sharing system to reimburse health insurers for financial losses resulting from a proposed ban on certain pharmaceutical-industry rebates in Medicare.
The backstop on most of insurers’ losses could help prevent premiums from rising significantly as a result of the rebate-rule changes, while making taxpayers responsible for a greater share of cost overruns in Medicare’s prescription-drug program.
